Cargando…
The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer
Numerous studies have shown that the blood of cancer patients are generally in hypercoagulable statement. The aim of the present research is to study the relationships of plasma fibrinogen (Fbg) levels with clinicopathological stages (CS) and tumor markers of non-small cell lung cancer (NSCLC). Base...
Autores principales: | Bian, Nan-Nan, Shi, Xin-Yu, Qi, Hong-Yu, Hu, Xin, Ge, Yang, An, Guang-Yu, Feng, Guo-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708950/ https://www.ncbi.nlm.nih.gov/pubmed/31393394 http://dx.doi.org/10.1097/MD.0000000000016764 |
Ejemplares similares
-
Plasma Fibrinogen as a Diagnostic Marker of Infection in Patients with Nonunions
por: Wang, Xiang-Jin, et al.
Publicado: (2020) -
The association of plasma fibrinogen with clinicopathological features and prognosis in esophageal cancer patients
por: Liu, Fang-Teng, et al.
Publicado: (2017) -
Prognostic value of preoperative plasma fibrinogen levels in resected stage I non‐small cell lung cancer
por: Mitsui, Suguru, et al.
Publicado: (2022) -
Association between plasma fibrinogen and survival in patients with small‐cell lung carcinoma
por: Fan, Shanshan, et al.
Publicado: (2017) -
Plasma fibrinogen: now also an antidepressant response marker?
por: Martins-de-Souza, D, et al.
Publicado: (2014)